Dudediligence.

Onconetix, Inc

ONCONASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$406,859Sep ’24$711,976Dec ’24$101,630Mar ’25$106,494Jun ’25$303,651Sep ’25$303,596Dec ’25$21,457Mar ’26$17,120Jun ’26
Net income, by quarter
−$3.8MSep ’24−$29.4MDec ’24−$8.5MMar ’25−$2.4MJun ’25−$8.8MSep ’25$5.7MDec ’25−$4.2MMar ’26−$2.9MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on filenone on file$58,465$2.5M$815,371
Gross profitnone on filenone on file−$1.1M$1.1M$632,913
Operating income−$3.4M−$13.5M−$36.0M−$56.5M−$17.9M
Net income−$3.4M−$13.4M−$37.4M−$58.7M−$14.0M
Operating cash flow−$2.0M−$8.7M−$13.6M−$10.5M−$9.7M
Free cash flow−$2.0M−$8.7M−$13.6M−$10.5Mnone on file
Cash$1.9M$25.8M$4.6M$646,500$5.2M
Shares outstanding3.2M15.3M558.1K138.3K1.6M